BioCube, Inc.
BICB
$0.0002
-$0.0022-91.67%
| 07/31/2013 | 04/30/2013 | 01/31/2013 | 10/31/2012 | 07/31/2012 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 307.90K | 387.30K | 379.20K | 322.40K | 300.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 307.90K | 387.30K | 379.20K | 322.40K | 300.70K |
| Operating Income | -307.90K | -387.30K | -379.20K | -322.40K | -300.70K |
| Income Before Tax | -914.10K | -903.40K | -764.50K | -566.50K | -286.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.91 | -0.90 | -0.76 | -0.57 | -0.29 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -914.10K | -903.40K | -764.50K | -566.50K | -286.20K |
| EBIT | -307.90K | -387.30K | -379.20K | -322.40K | -300.70K |
| EBITDA | -62.30K | -115.90K | -229.60K | -143.70K | -147.70K |
| EPS Basic | -0.03 | -0.03 | -0.02 | -0.02 | -0.01 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.01 | 0.00 |
| EPS Diluted | -0.03 | -0.03 | -0.02 | -0.02 | -0.01 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 160.55M | 144.15M | 124.80M | 122.62M | 119.26M |
| Average Diluted Shares Outstanding | 160.55M | 144.15M | 124.80M | 122.62M | 119.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
